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Proteinuria and the risk of developing end-stage renal disease. general population. Dipstick urinalysis is not usually rec-
Background. Dipstick urinalysis for proteinuria and hema- ommended for the purpose of screening for renal disease
turia has been used to screen renal disease, but evidence of because both evidence of the relationship between detec-the clinical impact of this test on development of end-stage
tion of proteinuria by dipstick urinalysis and long-termrenal disease (ESRD) is lacking.
renal survival and financial benefit are lacking.Methods. We assessed development of ESRD through 2000
in 106,177 screened patients (50,584 men and 55,593 women), Natural courses of progressive renal disease are mostly
20 to 98 years old, in Okinawa, Japan, who participated in unknown. Moreover, many patients come late to a nephrol-
community-based mass screening between April 1983 and
ogist and begin chronic dialysis therapy with only a shortMarch 1984. We used data from the Okinawa Dialysis Study
duration of follow-up [6, 7]. In Japan, Okinawa has aRegistry to identify ESRD patients. Multivariate logistic analy-
ses were performed to calculate adjusted odds ratio and 95% high incidence and prevalence of dialysis patients [1, 8].
confidence interval (95% CI) for the significance of proteinuria Since 1971, we have maintained a registry of all chronic
and hematuria on the risk of developing ESRD with confound- dialysis patients treated in Okinawa [9, 10]. The Okinawaing variables such as age, gender, blood pressure, and body
General Health Maintenance Association has run an inde-mass index. A similar analysis was repeated in a subgroup of
screened patients in whom serum creatinine data existed. pendent, community-based mass screening program, and
Results. During 17 years of follow-up, 420 screened persons the collected data have been filed in a computer since
(246 men and 174 women) entered the ESRD program. We 1983 [11]. We identified the individuals who developedidentified a strong, graded relationship between ESRD and
ESRD among those participating in the 1983 screening,dipstick urinalysis positive for proteinuria; adjusted odds ratio
and we examined the clinical impact of the degree of(95% CI) was 2.71 (2.51 to 2.92, P  0.001). Similar trends
were observed after adding serum creatinine data. Compared proteinuria measured by dipstick urinalysis.
with dipstick-negative proteinuria, adjusted odds ratio (95%
CI) of proteinuria (1) was 1.93 (1.53 to 2.41, P  0.001) in
men and 2.42 (1.91 to 3.06, P  0.001) in women. METHODS
Conclusion. Proteinuria was a strong, independent predictor
Study designof ESRD in a mass screening setting. Even a slight increase
in proteinuria was an independent risk factor for ESRD. There- All individuals over 20 years of age who participatedfore, asymptomatic proteinuria warrants further work-up and
in the 1983 mass health screening examinations in Oki-intervention.
nawa, Japan, were eligible for the study. Okinawa in-
cludes a number of subtropical islands and is located in
the southern-most part of Japan. The population is stableThe number of patients with end-stage renal disease
(ESRD) requiring chronic dialysis is increasing world- at around 1.2 million (1980 census). Screening partici-
wide [1, 2]. Therefore, it is necessary to detect early signs pants were excluded from the study if birth date data
of renal disease and determine who is at high risk of or dipstick urinalysis results were not available in the
developing ESRD. Proteinuria is a well-known marker computer file. Dialysis patients who had been among the
of renal disease, and reduction of proteinuria is often 1983 screening participants and those individuals who
associated with beneficial effect of treatment [3–5]. How- had become dialysis patients during the study period
ever, long-term renal survival based on the results of through December 31, 2000, were identified by using
dipstick urinalysis for proteinuria is not known in the the Okinawa Dialysis Study (OKIDS) Registry, which
covers the entire geographic area. Furthermore, the
Key words: proteinuria, hematuria, end-stage renal disease, screening. identity of these dialysis patients was verified by re-
viewing their medical charts in the dialysis units. TheReceived for publication August 26, 2002
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ing were determined. 2003 by the International Society of Nephrology
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Mass screening Dialysis registry in Okinawa
All chronic dialysis patients residing in Okinawa, Ja-The Okinawa General Health Maintenance Associa-
pan, who survived at least 1 month on scheduled dialysistion (OGHMA) under the direction of Dr. Y. Ikemiya
are registered in the OKIDS Registry [9, 10]. Patientsperforms a large community-based health examination
dying within 1 month of the start of dialysis are notannually. The association is a nonprofit organization that
included in the registry because it is unknown whetherwas founded in 1972. Once each year, the staff of the
their renal function was improving and whether otherassociation, doctors and nurses, visit sites where people
medical conditions accounted for their rapid demise. Per-reside or are employed throughout the entire Okinawa
tinent clinical information for the new dialysis patientsarea. Those who are screened have participated volunta-
and medical events in the prevalent dialysis patients wererily. They provide mass screening examinations, inform
collected almost perfectly by the collaboration of thethe participants of the results, and, when necessary, rec-
physicians acknowledged herein. Records were updatedommend further examination. The mass screening exam-
at least twice a year for medical events such as death,ination includes an interview regarding health status, a
renal transplantation, and patient transfer out of Oki-physical examination, a urine test, and blood tests. A
nawa. If needed, other information was obtained throughnurse or doctor measures blood pressure with a standard
nurses, medical clerks, and the patients themselves. Allmercury sphygmomanometer while the person being
patients were followed up until a major medical eventscreened is in the sitting position. Dipstick urinalysis
or until January 2001, whichever occurred first, and we(Ames dipstick) is performed with spontaneously voided
verified outcomes. Because Okinawa includes subtropi-fresh urine. The results of the urine test are interpreted
cal islands that are separated from mainland Japan, thereby the physicians or their assistants and are recorded as
is little migration of patients. Several retrospective [9, 10](), (), (1), (2), (3), and (4). We defined results
and prospective [13–15] studies based on the registry
recorded as () and () as normal, and the rest were
data have been reported.
defined as abnormal. Data for glycosuria and fasting
Criteria for the differential diagnosis of ESRD were
blood glucose were incomplete and were, therefore, not neither simple nor standardized. Therefore, the medical
analyzed in this study. Body mass index was calculated records were further reviewed, and patients were grouped
as weight in kilograms divided by the square of the height into one of six disease categories. Chronic glomerulo-
in meters. The computer-based data included data ac- nephritis was diagnosed when proteinuria and/or hema-
quired from April 1, 1983, through March 31, 1984. The turia was noted before the onset of hypertension and renal
present analysis was conducted on a total of 106,177 failure. Nephrosclerosis was diagnosed when hyperten-
screened persons (50,584 men and 55,593 women), which sion or major vascular disease was documented before
was approximately 13.7% of the total adult population the onset of renal failure. Diabetes mellitus nephropathy
in Okinawa in 1983. In men, the estimated proportion was diagnosed clinically by a long history of diabetes melli-
of the general population in each age group who partici- tus, presence of diabetes mellitus retinopathy, and the
pated was as follows: 6.8% in those 20 to 29 years of use of insulin [16]. Systemic lupus erythematosus was
age, 13.3% in those 30 to 39 years of age, 15.4% in those diagnosed according to the criteria of the American Rheu-
40 to 49 years of age, 16.8% in those 50 to 59 years of matism Association [17]. Polycystic kidney disease was
age, 22.1% in those 60 to 69 years of age, 22.2% in those diagnosed, after chart review, by the presence of multiple
70 to 79 years of age, and 14.2% in those 80 years old cysts and a family history of the disease. A sixth category,
and older. In women, it was 5.3% in those 20 to 29 years “other” disease, was used for patients who did not fall
of age, 10.4% in those 30 to 39 years of age, 15.1% in into one of the aforementioned disease categories.
those 40 to 49 years of age, 20.3% in those 50 to 59 years By the end of 2000, there were 46 dialysis units in Oki-
of age, 25.5% in those 60 to 69 years of age, 23.8% in nawa. Nine were in the public sector, 17 were in private
those 70 to 79 years of age, and 11.6% in those 80 years hospitals, and 20 were in clinics.
old and older. Because the cost for the blood test was
Statistical analysisnot paid for by the public sector, it was not mandatory.
Serum creatinine data were available for 14,609 screened The unpaired t test or the chi-square test was used to
persons [12]. Serum creatinine was measured using the analyze differences in values or ratios between groups.
modified method of Jaffe’s reaction in an automated The observation period was calculated from the date of
analyzer at OGHMA’s laboratory. Screened persons screening until the start of dialysis. Multivariate logistic
who were already on chronic dialysis were excluded from analysis was done to examine the correlates of protein-
the study. According to the 1980 census, the population uria by variables such as age, gender, systolic blood pres-
in Okinawa over 15 years of age was 781,166 (377,479 sure, diastolic blood pressure, and body mass index. In
a subgroup of screened persons, analyses were repeatedmen and 403,687 women).
Iseki et al: Urine test and end-stage renal disease1470
Table 2. Clinical demographics of screenees in 1983 who eventuallyTable 1. Clinical demographics of the screened subjects in 1983
developed end-stage renal disease (ESRD) by the end of 2000
Screened subjects
Total screened who developed end- Screened subjects
who developed Total ESRDsubjects stage renal disease
ESRD population
Number of screened subjects 106,177 420
Men 50,584 (47.6%) 246 (58.6%)a Number of patients 420 4569
Men 246 (58.6%) 2564 (56.1%)Age years, mean SD 49.1 (16.2) 52.9 (13.0)a
Body mass index kg/m2, Age at start of dialysis years,
mean SD 63.7 (13.5) 56.7 (16.4)amean SD 23.4 (3.3)a 24.4 (3.4)a
Systolic blood pressure Time to dialysis after screening
months, mean SD 129.1 (53.8)mm Hg, mean SD 130.2 (19.4) 143.9 (22.0)a
Diastolic blood pressure Primary renal disease
Chronic glomerulonephritis 205 (48.8%) 1955 (42.8%)mm Hg, mean SD 78.7 (11.4) 86.8 (12.7)a
Proteinuria % 5.3 44.3a Diabetes mellitus 100 (23.8%) 1542 (33.7%)a
Polycystic kidney disease 12 (2.9%) 111 (2.4%)Hematuria % 9.0 18.1a
Systemic lupus erythematosus 6 (1.4%) 100 (2.2%)Screening was performed from April 1983 to March 1984. Proteinuria (hema-
Nephrosclerosis 55 (13.1%) 490 (10.7%)turia) denotes 1 and over by dipstick test.
Other 42 (10.0%) 371 (8.1%)aP  0.001
Screening was performed from April 1983 to March 1984. Study period was
from April 1983 to December 2000.
aP  0.001
with addition of serum creatinine. Data are expressed
as mean (SD). All analyses were done with SAS (Version
8.2, SAS Institute, Inc., Cary, NC, USA). P  0.05 was Impacts of different degrees of proteinuria and hema-
considered statistically significant. turia on the risk of developing ESRD are summarized for
both men and women (Table 4). Even a slight increase in
the degree of proteinuria, such as proteinuria (), causedRESULTS
a change in the adjusted odds ratios (95% CI), whichThe characteristics of the participants in this analysis
were 1.77 (1.13 to 2.78, P  0.012) in men and 1.34 (0.74are shown in Table 1. During the follow-up period, 420
to 2.41, not significant) in women. The relation betweensubjects entered the dialysis program (Table 2). The
the risk of ESRD and the degree of hematuria, however,mean time to dialysis after screening was 141.4 months
was different from that of proteinuria (Table 5). Ratesin patients with proteinuria (), and it decreased with
of ESRD adjusted for age and gender were shown by athe degree of proteinuria to 103.9 months with protein-
combination of proteinuria and hematuria (Fig. 4).uria (3), P  0.01. The cumulative incidence of ESRD
increased sharply and linearly with the degree of protein-
uria (Figs. 1 and 2) but did not increase much with that DISCUSSION
of hematuria (Fig. 3).
Our study confirmed the link between proteinuria orRisk of developing ESRD was evaluated by multivari-
hematuria and ESRD. Compared to hematuria, protein-ate logistic analysis. Proteinuria was a strong, indepen-
uria was a more potent predictor of ESRD than wasdent risk factor for developing ESRD. Overall, the non-
hematuria in both men and women. Even a slight degreeadjusted odds ratio (95% CI) and adjusted odds ratio
of proteinuria, such as proteinuria () for men and pro-(95% CI) were 3.09 (2.89 to 3.31, P  0.001) and 2.71
teinuria (1) for women, was a significant predictor of(2.51 to 2.92, P  0.001) for proteinuria and 1.43 (1.30
ESRD. Proteinuria is also a predictor of all-cause mortal-to 1.57, P  0.001) and 1.18 (1.06 to 1.32, P  0.002)
ity [18, 19]. Those who had higher degrees of proteinuriafor hematuria in model 1 (Table 3). Hematuria was a
may have died before reaching ESRD [20]. Therefore,significant risk factor for ESRD for men (odds ratio,
our findings may underestimate the impact of the degree1.38; 95% CI, 1.19 to 1.61, P  0.001), but not women
of proteinuria on development of ESRD.(odds ratio, 1.02; 95% CI, 0.87 to 1.19, not significant).
The relation between microalbuminuria and cardio-In a subgroup of screened subjects, similar analyses were
vascular disease is well established, and microalbumin-repeated with adding data of serum creatinine in model
uria, proteinuria, or both are predictors of cardiovascular2. Overall, proteinuria remained significant (odds ratio,
disease in patients with diabetes, hypertension, or both.2.53; 95% CI, 2.17 to 2.94, P  0.001), but hematuria
It is plausible that intrarenal vascular disease causes glo-was not (odds ratio, 1.13; 95% CI, 0.95 to 1.36). In men,
merular and tubular damage that, in turn, causes micro-the odds ratios (95% CI) were 2.64 (2.04 to 3.42, P 
albuminuria. Therefore, screening for proteinuria could0.001) for proteinuria and 2.66 (1.41 to 5.01, P  0.003)
help identify patients who are at high risk for cardiovas-for hematuria. In women, the odds ratios (95% CI) were
cular disease and ESRD.2.32 (1.84 to 2.93, P  0.001) for proteinuria and 1.05
(0.81 to 1.36, not significant) for hematuria. Cumulative incidence of ESRD increased linearly with
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Fig. 1. Cumulative incidence of end-stage re-
nal disease (ESRD) by the baseline results for
proteinuria. There are some screened persons
with no data for proteinuria. The study period
was from April 1983 to December 2000.
Fig. 2. Cumulative incidence of end-stage re-
nal disease (ESRD) by the time after screen-
ing in each degree of proteinuria. Study period
was from April 1983 to December 2000. Sym-
bols are: (), proteinuria 3; (), protein-
uria 2; (), proteinuria ; (), proteinuria
; and (), proteinuria .
the degree of proteinuria (Fig. 1). The cumulative in- uria in a cross-sectional population-based study [21, 22].
In the present study, proteinuria was a significant, indepen-cidence of ESRD was 1.4% in the screened persons
with proteinuria (1) and 7.1% in the screened persons dent predictor of ESRD, even after adjustment for body
mass index (Table 3). Smoking is a significant risk factorwith proteinuria (2) for the 17-year follow-up period.
Screened persons with proteinuria (2) or more are at for proteinuria in various clinical settings [23, 24]. Unfortu-
nately, lifestyle-related variables such as smoking, drinking,high risk of ESRD; therefore, they are candidates for
further workups. However, for those with proteinuria and exercise were not included in this study. Incidence of
hematuria was higher in women than in men. However,(1) and (), the absolute risk of ESRD was not as
high, meaning further workups may not be necessary, hematuria was not helpful to predict for ESRD in women.
Risk of developing ESRD with isolated hematuria inunless otherwise indicated.
Proteinuria is relatively common in obese subjects. Body women was similar to that of normal urinalysis.
There are several limitations in the present study. Dip-mass index was significantly correlated with microalbumin-
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Fig. 3. Cumulative incidence of end-stage re-
nal disease (ESRD) by the baseline results for
hematuria. There are some screened persons
with no data for hematuria. The study period
was from April 1983 to December 2000.
Table 4. Results of multivariate analysis on the risk of developingTable 3. Results of multivariate logistic analysis on the risk of
end-stage renal disease (ESRD) end-stage renal disease (ESRD) based on the degree of
proteinuria by dipstick urinalysis
Variables OR 95% CI P value
Variables OR 95% CI P value
Proteinuria
Model 1 Men
Proteinuria () 1.00Overall 2.71 2.51–2.92 0.001
Men 2.62 2.36–2.90 0.001 Proteinuria () 1.77 1.13–2.78 0.012
Proteinuria (1) 1.93 1.53–2.41 0.001Women 2.81 2.50–3.15 0.001
Model 2 Proteinuria (2) 2.95 2.59–3.37 0.001
Proteinuria (3) 2.60 2.28–2.96 0.001Overall 2.53 2.17–2.94 0.001
Men 2.64 2.04–3.42 0.001 Proteinuria (4) 2.56 1.51–4.34 0.001
WomenWomen 2.32 1.84–2.93 0.001
Hematuria Proteinuria () 1.00
Proteinuria () 1.34 0.74–2.41 NSModel 1
Overall 1.18 1.06–1.32 0.002 Proteinuria (1) 2.42 1.91–3.06 0.001
Proteinuria (2) 2.66 2.26–3.14 0.001Men 1.38 1.19–1.61 0.001
Women 1.02 0.87–1.19 NS Proteinuria (3) 2.81 2.45–3.22 0.001
Proteinuria (4) 3.43 2.21–5.31 0.001Model 2
Overall 1.13 0.95–1.36 NS NS is not significant. Odds ratio (OR) and 95% confidence interval (95% CI)
Men 2.66 1.41–5.01 0.003 were calculated with adjustment for age, hematuria, systolic blood pressure,
Women 1.05 0.81–1.36 NS diastolic blood pressure, and body mass index. The study period was from April
1983 to December 2000.NS is not significant. Proteinuria and hematuria are grouped into six groups
by the results of dipstick urinalysis as (), (), (1), (2), (3), and (4).
Variables in model 1 were age, gender, systolic and diastolic blood pressure,
and body mass index and variables in model 2 were the variables in model 1
plus serum creatinine. The study period was from April 1983 to December 2000.
the serum creatinine subgroup. Serum creatinine was
measured in about 14% of the screened population. The
reasons for serum creatinine measurement in this screen-
stick urinalysis was measured on only one occasion, re- ing are not known. The test may have possibly been
sulting in an underestimation of the strength of the asso- ordered by physicians, or the subjects requested it be-
ciation of ESRD with proteinuria and hematuria. An cause of concerns about abnormal kidney function. How-
average value, determined from measurements taken on ever, the percentage of abnormally high serum creatinine
multiple occasions, would yield greater differences in the of 2.0 mg/dL have been as low as 0.28% in 1983 (N 
incidence of ESRD associated with abnormal urinalysis. 14,609) and 0.15% in 1992 (N 91,033) in this screening
We were not certain of the causes of proteinuria in this program. The type of primary renal disease in the ESRD
study. Even in patients with benign nephrosclerosis, sig- of the screened individuals was slightly different from
that of the entire ESRD population in Okinawa duringnificant rates of proteinuria were observed. Transient
proteinuria was reported to be 4% in men and 8% in the study period. Of the screened individuals, 23.8% had
ESRD caused by diabetes mellitus, whereas the rate ofwomen, with resolution on subsequent examination [25].
Renal function was not measured at baseline, except in ESRD caused by diabetes mellitus in the entire popula-
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Table 5. Results of multivariate analysis on the risk of developing
end-stage renal disease (ESRD) based on the degree of
hematuria by dipstick urinalysis
Variables OR 95% CI P value
Men
Hematuria () 1.00
Hematuria () 1.38 0.96–1.96 NS
Hematuria (1) 1.73 1.39–2.15 0.001
Hematuria (2) 1.45 1.14–1.84 0.002




Hematuria () 0.67 0.45–1.00 NS
Hematuria (1) 0.76 0.56–1.04 NS
Hematuria (2) 1.16 0.97–1.40 NS
Hematuria (3) 1.04 0.79–1.35 NS
Hematuria (4) 2.66 1.51–4.67 0.001
NS is not significant. Odds ratio (OR) and 95% confidence interval (95% CI)
were calculated with adjustment for age, urinalysis, systolic blood pressure, dia-
stolic blood pressure, and body mass index. NA was not assessed because no
men tested for hematuria (4). The study period was from April 1983 to Decem-
ber 2000.
Fig. 4. Rate of end-stage renal disease (ESRD), per 1000 in 17 years
of follow-up, adjusted for age and gender by the results of dipstick
tion was 33.7% during this study period. Unfortunately, measurement for proteinuria and hematuria. The study period was from
April 1983 to December 2000.data for glycosuria and fasting blood glucose were not
available in the 1983 screening. We also have no informa-
tion regarding the onset of urinary tract malignancies
and kidney stone disease in this cohort. The incidence nen, Y. Oshiro, K. Nakama, K. Nakao, O. Shiranezawa, K. Nagasawa,
and prevalence of ESRD are high in Okinawa, yet the H. Uchima, T. Higa, A. Higa, K. Yoshihara, M. Maeshiro, S. Miyagi,
T. Kinjo, M. Ishu, H. Yoshimura, Y. Arakaki, N. Nakamura, H. Kinjo,reasons for this are not clear. Regional variations in
O. Shinjo, T. Nakanishi, I. Shiroma, S. Shiroma, K. Ishikawa, K. Nagata,the incidence and prevalence of ESRD are increasingly K. Akamine, T. Tana, S. Oshiro, N. Tomiyama, K. Kohagura, H.
recognized; therefore, our results may need to be con- Muratani, Professor Y. Ogawa, ex-Prof. A. Osawa, and ex-Prof. K.
Fukiyama. The authors are grateful to Dr. O. Morita for helping withfirmed in other regions or countries.
data processing and statistical analysis.Economic and social burdens of ESRD are increasing
as patient age or become ill. Identification of modifiable Reprint requests to Kunitoshi Iseki, M.D., Dialysis Unit, University
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